Condition: Pulmonary Disease · Critical Illness · Sponsor: Oregon Health and Science University
This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.
This description comes directly from the study's public registry record.
Laura H Nguyen, B.S. · 503-418-4733 · nguyelau@ohsu.edu
Albert Chi, M.D., F.A.C.S · 503-494-5300 · chia@ohsu.edu
Always discuss trial participation with your own doctor first.
| Oregon Health and Science University | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06775106